We are live on ! Find out more
MSS

Mitchell Sinkler & Starr Portfolio holdings

AUM $240M
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+0.08%
1 Year Est. Return
+24.63%
3 Year Est. Return
+72.22%
5 Year Est. Return
+87.27%
10 Year Est. Return
+266.58%
AUM
$456M
AUM Growth
Cap. Flow
+$464M
Cap. Flow %
101.68%
Top 10 Hldgs %
37.08%
Holding
153
New
153
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$26.7M
2
XOM icon
ExxonMobil
XOM
+$26.2M
3
MRK icon
Merck
MRK
+$23.3M
4
PG icon
Procter & Gamble
PG
+$22.4M
5
GE icon
GE Aerospace
GE
+$14.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 21.13%
2 Consumer Staples 16.65%
3 Energy 14.82%
4 Industrials 12.86%
5 Technology 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
A icon
151
Agilent Technologies
A
$39.1B
$220K 0.05%
+7,204
New +$224K
EPD icon
152
Enterprise Products Partners
EPD
$83.8B
$202K 0.04%
+6,500
New +$197K
OPTT icon
153
Ocean Power Technologies
OPTT
$38.3M
$19K ﹤0.01%
+60
New +$19.6K

Similar funds

Mitchell Sinkler & Starr's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Mitchell Sinkler & Starr, which disclosed 153 positions worth $456M. Its ten largest holdings account for 37% of the portfolio.

Its largest position is Johnson & Johnson: 315,040 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, followed by Consumer Staples and Energy.

  • Mitchell Sinkler & Starr's largest Q2 2013 buy was Johnson & Johnson: 315,040 shares worth $27M.
  • Mitchell Sinkler & Starr's ten largest holdings make up 37% of its $456M portfolio in Q2 2013.
  • Mitchell Sinkler & Starr disclosed 153 positions in Q2 2013, its first 13F filing on record.

Based on Mitchell Sinkler & Starr's 13F filing for Q2 2013, filed 24 Jul 2013.